MassTort-National Talc Powder Ovarian Cancer Product Liability Claims: Johnson & Johnson Faces 67,000+ Consolidated Lawsuits After a New Jersey Federal Court Disqualifies Lead Plaintiff Counsel, Attorney911 Brings Ralph Manginello’s 27+ Years of Federal-Court Trial Practice to Women Diagnosed With Ovarian Cancer From Talc-Based Body Powder, We Pursue the Manufacturer and Its Corporate Subsidiaries for Design Defect, Failure to Warn and Decades of Fraudulent Concealment, the Perineal Talc Exposure Pathway and Carcinogenic Inflammation Mechanism, We Secure J&J Internal Safety Testing Communications and Laboratory Records Before They Vanish, Lupe Peña the Former Insurance-Defense Insider Who Knows How Corporate Claims Teams Value and Deny Cancer Cases, the Firm Has Recovered Millions in Catastrophic Injury and Wrongful-Death Cases, FDA Cosmetic-Product Oversight and Products-Liability Doctrine, Your State’s Statute of Limitations Is Running — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911
The Talc Verdict Is Still Coming — What the Federal Court’s Disqualification Ruling Means for Your Ovarian Cancer Claim You just read the headline. A federal court kicked a major plaintiff firm off the biggest talc litigation in the country — more than 67,000 women’s claims against Johnson & Johnson, consolidated in a New Jersey federal courtroom, and the firm that was helping steer those cases has been barred from representing them. The ruling came down March 26, 2026, in a 41-page opinion that described a decade of litigation turned bitter and a collaboration that crossed an ethical line. If you are a woman who used talc-based body powder for years and was later diagnosed with ovarian cancer, that headline landed in your chest like a bad scan result. You are thinking: Does this mean my case is dead? Did the court just say the science was wrong? Did J&J win? No. No. And no. What the court did was punish a law firm for how it handled a specific ethical question — not question whether Johnson & Johnson’s talc caused cancer, not question whether the women’s claims are valid, and not dismiss a single plaintiff’s case. The underlying litigation moves forward. The science linking perineal talc use to ovarian cancer remains well-established in the published epidemiological literature and has supported numerous plaintiff verdicts across multiple jurisdictions. Johnson & Johnson remains the defendant. The 67,000-plus claims remain alive. What changed is who is sitting in the chair for a portion…